Bicycle therapeutics to participate in upcoming investor conferences

Cambridge, england & boston--(business wire)--bicycle therapeutics plc (nasdaq:bcyc), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (bicycle®) technology, today announced that management will participate in the following investor conferences in november: td cowen 7th annual fall oncology innovation summit on friday, november 3, 2023; fireside chat at 10:00 a.m. et jefferies london healthcare conference on wednesday, n.
BCYC Ratings Summary
BCYC Quant Ranking